Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the ris

Abstract

Inflammation plays a pivotal role in the pathogenesis of atherosclerosis. Previous reports have used vaccination as a model to stimulate inflammation. The aim of the present study was to investigate the role of C-reactive protein response to PCI in the risk of clinical restenosis or new coronary stenosis, considering PCI as a model to stimulate inflammation.

Material and methods
Eight hundred and ninety-one patients with stable or unstable angina pectoris and with normal serum troponin T ≤ 0.03 μg/L before PCI were investigated. The survivors after a follow-up period of 2.6 years (850 patients) were included. Serum C-reactive Protein CRP and troponin T concentration were measured before and the day after PCI. Restenosis and new coronary stenosis, detected by coronary angiography due to symptomatic coronary heart disease, were determined.

Results
C-reactive Protein response to PCI, unstable angina pectoris, the number of vessels dilated and lack of stent implantation were associated with restenosis or new coronary stenosis. In multivariate analysis, patients in the highest tertile of CRP, induced by PCI, had an increased risk (risk ratio 1.7 [95% CI 1.1–2.9]) for restenosis or new coronary stenosis. Furthermore, patients with restenosis had an increased CRP response to PCI compared with those with new coronary stenosis.

Conclusion
The C-reactive Protein response to PCI, as a model to stimulate inflammation, is associated with an increased risk of clinical restenosis. The results emphasize the role of CRP in the pathogenesis of coronary artery disease progression and in particular restenosis.

Atherosclerosis
Volume 195, Issue 2, December 2007, Pages 374-378
i:10.1016/j.atherosclerosis.2006.10.026
aKarolinska University Hospital, Karolinska Institute, Stockholm, Sweden

Human C-Reactive Protein Latest Research

THE LATEST IN Human C-Reactive Protein (CRP) Research:
Transgenic expression of human C-Reactive Protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury .These in vivo observations support the hypothesis that C-reactive Protein modulates NO metabolism and may have implications regarding the mechanisms by which CRP modulates vascular disease. Source: Am J Physiol Heart Circ Physiol 293: H489-H495, 2007

human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis. human C-Reactive Protein also enhanced myeloma cell secretion of IL-6 and synergized with IL-6 to protect myeloma cells from chemotherapy drug-induced apoptosis. Thus, our results implicate CRP as a potential target for cancer treatment.Source: Cancer Cell, Vol 12, 252-265, 11 September 2007